Aeglea BioTherapeutics, Inc. (AGLE) has 20 known insider and institutional holders on record. The largest holder is Alspaugh Jonathan with 19,787,969 shares. Other notable holders include King-Jones Heidy and Novartis Bioventures Ltd.
AGLE Insider Ownership
Top Holder
Alspaugh Jonathan
19,787,969 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Alspaugh Jonathan |
President and CFO |
19,787,969 |
2023-06-30 |
|
| 2 |
King-jones Heidy |
See Remarks |
13,495,255 |
2023-09-05 |
|
| 3 |
Novartis Bioventures Ltd |
Officer |
2,175,314 |
2018-05-14 |
|
| 4 |
Lilly Eli & Co |
10 Percent Owner |
2,068,543 |
2016-04-14 |
|
| 5 |
Cox Russell J. |
Director |
1,950,000 |
2023-06-30 |
|
| 6 |
Magovcevic-liebisch Ivana |
Director |
1,950,000 |
2023-06-30 |
|
| 7 |
Smith Hunter C |
Director |
1,950,000 |
2023-06-30 |
|
| 8 |
Lawton Alison Frances |
Director |
1,950,000 |
2023-06-30 |
|
| 9 |
Goldberg Jeff Marc |
President and CEO |
1,884,838 |
2022-12-01 |
|
| 10 |
Orbimed Advisors Llc |
10 Percent Owner |
1,390,724 |
2017-02-21 |
|
| 11 |
Quinn Anthony G. |
President & CEO |
550,540 |
2022-03-18 |
|
| 12 |
Neuman Linda L |
Chief Medical Officer |
550,000 |
2023-02-24 |
|
| 13 |
Kastenmayer James Paul |
General Counsel |
500,000 |
2023-02-24 |
|
| 14 |
Hanley Jr. Michael Conick |
Chief Business Officer |
500,000 |
2023-02-24 |
|
| 15 |
Turtle Cameron |
Chief Executive Officer |
374,000 |
2023-11-27 |
|
| 16 |
Rojas-caro Sandra |
Chief Medical Officer |
200,000 |
2016-05-19 |
|
| 17 |
Lowe David George |
CEO and President |
160,000 |
2017-03-22 |
|
| 18 |
Burrows Scott L |
Chief Financial Officer |
134,953 |
2023-12-22 |
|
| 19 |
Sloan Leslie |
Chief Operating Officer |
130,000 |
2022-08-25 |
|
| 20 |
York Charles N Ii |
Chief Financial Officer and VP |
126,000 |
2020-02-19 |
|
No ownership data available for AGLE.
